These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 17407002)
21. [Hyperlipoproteinemia in glycogenosis and its treatment]. Chibisov IV; Karmanskiĭ IM Pediatriia; 1982 Feb; (2):6-9. PubMed ID: 6951139 [No Abstract] [Full Text] [Related]
22. Glycogen storage disease in adults. Talente GM; Coleman RA; Alter C; Baker L; Brown BI; Cannon RA; Chen YT; Crigler JF; Ferreira P; Haworth JC; Herman GE; Issenman RM; Keating JP; Linde R; Roe TF; Senior B; Wolfsdorf JI Ann Intern Med; 1994 Feb; 120(3):218-26. PubMed ID: 8273986 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of cornstarch therapy in type III glycogen-storage disease. Gremse DA; Bucuvalas JC; Balistreri WF Am J Clin Nutr; 1990 Oct; 52(4):671-4. PubMed ID: 2403059 [TBL] [Abstract][Full Text] [Related]
24. Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type Ia. Marfaing-Koka A; Wolf M; Boyer-Neumann C; Meyer D; Odievre M; Labrune P J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):566-70. PubMed ID: 14581798 [TBL] [Abstract][Full Text] [Related]
25. Muscle Ultrasound in Patients with Glycogen Storage Disease Types I and III. Verbeek RJ; Sentner CP; Smit GP; Maurits NM; Derks TG; van der Hoeven JH; Sival DA Ultrasound Med Biol; 2016 Jan; 42(1):133-42. PubMed ID: 26437929 [TBL] [Abstract][Full Text] [Related]
26. Alterations in erythrocyte membrane fluidity and fatty acid composition in glycogen storage disease. Keddad K; Thérond P; Motta C; Baussan C; Legrand A Biochim Biophys Acta; 1996 Jan; 1315(1):61-5. PubMed ID: 8611649 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of the biotinidase activity in hepatic glycogen storage disease patients. Undescribed genetic finding associated with atypical enzymatic behavior: an outlook. Angaroni CJ; Giner-Ayala AN; Hill LP; Guelbert NB; Paschini-Capra AE; Dodelson de Kremer R J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S289-94. PubMed ID: 20532819 [TBL] [Abstract][Full Text] [Related]
28. Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases. Sluiter W; van den Bosch JC; Goudriaan DA; van Gelder CM; de Vries JM; Huijmans JG; Reuser AJ; van der Ploeg AT; Ruijter GJ Clin Chem; 2012 Jul; 58(7):1139-47. PubMed ID: 22623745 [TBL] [Abstract][Full Text] [Related]
29. Glucose recycling and production in glycogenosis type I and III: stable isotope technique study. Kalderon B; Korman SH; Gutman A; Lapidot A Am J Physiol; 1989 Sep; 257(3 Pt 1):E346-53. PubMed ID: 2782400 [TBL] [Abstract][Full Text] [Related]
30. [Mitochondrial dysfunction in children with hepatic forms of glycogen storage disease]. Kurbatova OV; Izmaĭlova TD; Surkov AN; Namazova-Baranova LS; Poliakova SI; Miroshkina LV; Semenova GF; Samokhina IV; Kapustina EIu; Dukhova ZN; Potapov AS; Petrichuk SV Vestn Ross Akad Med Nauk; 2014; (7-8):78-84. PubMed ID: 25563007 [TBL] [Abstract][Full Text] [Related]
34. Impact of glycogen storage disease type I on adult daily life: a survey. Garbade SF; Ederer V; Burgard P; Wendel U; Spiekerkoetter U; Haas D; Grünert SC Orphanet J Rare Dis; 2021 Sep; 16(1):371. PubMed ID: 34479584 [TBL] [Abstract][Full Text] [Related]
35. Glycogen storage disease type I: diagnosis and phenotype/genotype correlation. Matern D; Seydewitz HH; Bali D; Lang C; Chen YT Eur J Pediatr; 2002 Oct; 161 Suppl 1():S10-9. PubMed ID: 12373566 [TBL] [Abstract][Full Text] [Related]
36. Hepatic glycogen storage disorders: what have we learned in recent years? Burda P; Hochuli M Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):415-21. PubMed ID: 26001652 [TBL] [Abstract][Full Text] [Related]
37. [Characteristics of lipid metabolism and the cardiovascular system in glycogenosis types I and III]. Polenova NV; Strokova TV; Starodubova AV Ter Arkh; 2017; 89(8):88-94. PubMed ID: 28914857 [TBL] [Abstract][Full Text] [Related]
38. Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring. Halaby CA; Young SP; Austin S; Stefanescu E; Bali D; Clinton LK; Smith B; Pendyal S; Upadia J; Schooler GR; Mavis AM; Kishnani PS Genet Med; 2019 Dec; 21(12):2686-2694. PubMed ID: 31263214 [TBL] [Abstract][Full Text] [Related]
39. Serum concentrations of extracellular matrix components: novel markers of metabolic control and hepatic pathology in glycogen storage disease? Calçado A; Trivedi P; Portmann B; Mowat AP J Pediatr Gastroenterol Nutr; 1991 Jul; 13(1):1-9. PubMed ID: 1919939 [TBL] [Abstract][Full Text] [Related]
40. Diagnosis of hepatic glycogen storage disease patients with overlapping clinical symptoms by massively parallel sequencing: a systematic review of literature. Beyzaei Z; Geramizadeh B; Karimzadeh S Orphanet J Rare Dis; 2020 Oct; 15(1):286. PubMed ID: 33054851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]